Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist
Contact+90 (538) 677 60 18

AI-Detected INSULIN RESISTANCE Increases the Risk of 12 Types of Cancer

AI-Detected INSULIN RESISTANCE Increases the Risk of 12 Types of Cancer
In this article
Nature Communications • February 2026

CANCER’S HIDDEN BIOLOGICAL ENGINE

AI-IR, a new digital score developed using artificial intelligence to estimate insulin resistance in the body, sheds light not only on a person’s weight but also on their metabolic risk. This feature offers a notable innovation for early cancer diagnosis and more accurate selection of individuals at risk.

Why does this study represent a clinical revolution?
We have long known that diabetes and obesity increase cancer risk. However, “insulin resistance”, the main bridge between these two conditions, was a parameter that was difficult to measure in routine clinical practice (because gold-standard methods are laborious) and often overlooked. Published in Nature Communications, this study shows that a “digital insulin resistance score” (AI-IR), generated by artificial intelligence from 9 basic clinical data points without complex laboratory tests, can illuminate not only an individual’s diabetes risk but also their susceptibility to 12 different types of cancer like a beacon.

A digital biomarker: how does the AI-IR model work?

Instead of the complex “clamp” technique used to detect insulin resistance, the researchers developed a machine learning algorithm that brings together parameters routinely measured in every hospital. AI-IR is the name of this model, which achieves a high accuracy of 88% (AUC: 0.88) by analyzing the following 9 parameters:

The 9 Clinical Data Points That Feed the Algorithm

Age
Sex
Race
Body Mass Index (BMI)
Fasting Glucose
HbA1c
Triglycerides
Total Cholesterol
HDL (Good Cholesterol)

This massive analysis of UK Biobank data from 372395 cancer-free individuals proved that the AI-IR score is far superior to traditional methods such as BMI and metabolic syndrome in predicting diabetes.

The relationship between 12 types of cancer and insulin resistance

The study revealed that cancer risk increased significantly in individuals with high AI-IR scores. The statistically strongest associations (after “Bonferroni” correction) were identified for the following types:

2.34-Fold Uterine Cancer HR: 2.34 (95% CI: 2.06-2.65)

It stands out as the cancer type most strongly associated with insulin resistance.

1.55-Fold Kidney Cancer HR: 1.55 (95% CI: 1.36-1.77)
1.46-Fold Esophageal Cancer HR: 1.46 (95% CI: 1.25-1.71)
1.29-Fold Pancreatic Cancer HR: 1.29 (95% CI: 1.11-1.49)

In addition to these main cancers, colon, breast (in women), stomach, liver, gallbladder, leukemia, and lung cancer risks were also observed to increase in direct proportion to the insulin resistance score. In the composite cancer analysis, an age- and sex-adjusted increase in risk of %25 was calculated.

Weight is not everything: BMI-independent risks

One of the most striking findings for the oncology community is that the effect of insulin resistance cannot be explained simply by “being overweight”. Even when the researchers adjusted the data for Body Mass Index (BMI), they found that the effect of insulin resistance on cancer persisted.

Lung Cancer in Particular: Surprisingly, the effect of insulin resistance on lung cancer risk is independent of BMI. This effect is most pronounced in individuals who have quit smoking (previous smokers). This proves how chronic inflammation and metabolic disruption act as insidious allies on the cancer journey.

In contrast, the relationship between insulin resistance and skin cancer was found to be inverse (HR: 0.85) in the study, leaving a question about how metabolic processes can produce different responses in different tissues.

Healing begins with metabolic honesty

In our story with cancer, we often focus on a tumor’s genetic code, but sometimes neglect the metabolic health of the “soil” (the body) that harbors it. This study whispers to us that insulin resistance is a silent storm that disturbs the calm of cells and pushes them toward becoming cancerous.

This digital biomarker (AI-IR) offered by artificial intelligence is part of our vision of precise guidance in oncology. Rather than simply saying “watch your weight”, we can now map an individual’s metabolic risk and seize the chance for early diagnosis through targeted screening. Healing means restoring harmony to the body’s biological orchestra (the balance of insulin and sugar).

Scientific sources and further reading

  • 1. Lee CL, et al. (2026). Machine learning-predicted insulin resistance is a risk factor for 12 types of cancer. Nature Communications.
  • 2. UK Biobank Prospective Cohort Study (2006-2022). Cardiovascular and Cancer Incidence Analysis.
  • 3. HOMA-IR and Hyperinsulinemic-euglycemic clamp validation studies. Journal of Clinical Investigation.
DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

AI-Detected INSULIN RESISTANCE Increases the Risk of 12 Types of Cancer

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy